<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36592929</PMID><DateCompleted><Year>2023</Year><Month>03</Month><Day>08</Day></DateCompleted><DateRevised><Year>2023</Year><Month>03</Month><Day>08</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><Volume>299</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>A liquid-to-solid phase transition of Cu/Zn superoxide dismutase 1 initiated by oxidation and disease mutation.</ArticleTitle><Pagination><StartPage>102857</StartPage><MedlinePgn>102857</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102857</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbc.2022.102857</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0021-9258(22)01300-X</ELocationID><Abstract><AbstractText>Cu/Zn superoxide dismutase 1 (SOD1) has a high propensity to misfold and form abnormal aggregates when it is subjected to oxidative stress or carries mutations associated with amyotrophic lateral sclerosis. However, the transition from functional soluble SOD1 protein to aggregated SOD1 protein is not completely clear. Here, we propose that liquid-liquid phase separation (LLPS) represents a biophysical process that converts soluble SOD1 into aggregated SOD1. We determined that SOD1 undergoes LLPS in&#xa0;vitro and cells under oxidative stress. Abnormal oxidation of SOD1 induces maturation of droplets formed by LLPS, eventually leading to protein aggregation and fibrosis, and involves residues Cys111 and Trp32. Additionally, we found that pathological mutations in SOD1 associated with ALS alter the morphology and material state of the droplets and promote the transformation of SOD1 to solid-like oligomers which are toxic to nerve cells. Furthermore, the fibrous aggregates formed by both pathways have a concentration-dependent toxicity effect on nerve cells. Thus, these combined results strongly indicate that LLPS may play a major role in pathological SOD1 aggregation, contributing to pathogenesis in ALS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Siyu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Ming</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Long</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shi</LastName><ForeName>Xiangyan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Biology, Shenzhen MSU-BIT University, Shenzhen, Guangdong Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Shi-Zhong</ForeName><Initials>SZ</Initials><AffiliationInfo><Affiliation>Beijing Key Laboratory of Bioprocess, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China. Electronic address: luosz@mail.buct.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017510" MajorTopicYN="N">Protein Folding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="Y">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D044367" MajorTopicYN="N">Phase Transition</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SOD1</Keyword><Keyword MajorTopicYN="N">aggregation</Keyword><Keyword MajorTopicYN="N">liquid-liquid phase separation</Keyword><Keyword MajorTopicYN="N">neurodegenerative diseases</Keyword><Keyword MajorTopicYN="N">oxidation</Keyword></KeywordList><CoiStatement>Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>4</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>2</Day><Hour>19</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36592929</ArticleId><ArticleId IdType="pmc">PMC9898760</ArticleId><ArticleId IdType="doi">10.1016/j.jbc.2022.102857</ArticleId><ArticleId IdType="pii">S0021-9258(22)01300-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bruijn L.I., Houseweart M.K., Kato S., Anderson K.L., Anderson S.D., Ohama E., et al. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science. 1998;281:1851&#x2013;1854.</Citation><ArticleIdList><ArticleId IdType="pubmed">9743498</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruijn L.I., Becher M.W., Lee M.K., Anderson K.L., Jenkins N.A., Copeland N.G., et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron. 1997;18:327&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pubmed">9052802</ArticleId></ArticleIdList></Reference><Reference><Citation>Beers D.R., Henkel J.S., Xiao Q., Zhao W., Wang J., Yen A.A., et al. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2006;103:16021&#x2013;16026.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1613228</ArticleId><ArticleId IdType="pubmed">17043238</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleveland D.W., Rothstein J.D. From charcot to lou gehrig: deciphering selective motor neuron death in als. Nat. Rev. Neurosci. 2001;2:806&#x2013;819.</Citation><ArticleIdList><ArticleId IdType="pubmed">11715057</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilieva H., Polymenidou M., Cleveland D.W. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J.&#xa0;Cell Biol. 2009;187:761&#x2013;772.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2806318</ArticleId><ArticleId IdType="pubmed">19951898</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciryam P., Lambert-Smith I.A., Bean D.M., Freer R., Cid F., Tartaglia G.G., et al. Spinal motor neuron protein supersaturation patterns are associated with inclusion body formation in ALS. Proc. Natl. Acad. Sci. U. S. A. 2017;114:E3935&#x2013;e3943.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5441770</ArticleId><ArticleId IdType="pubmed">28396410</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson J., Thomas K.A., Rubin B.H., Richardson D.C. Crystal structure of bovine Cu,Zn superoxide dismutase at 3 A resolution: chain tracing and metal ligands. Proc. Natl. Acad. Sci. U. S. A. 1975;72:1349&#x2013;1353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC432531</ArticleId><ArticleId IdType="pubmed">1055410</ArticleId></ArticleIdList></Reference><Reference><Citation>Klug D., Rabani J., Fridovich I. A&#xa0;direct demonstration of the catalytic action of superoxide dismutase through the use of pulse radiolysis. J.&#xa0;Biol. Chem. 1972;247:4839&#x2013;4842.</Citation><ArticleIdList><ArticleId IdType="pubmed">4626367</ArticleId></ArticleIdList></Reference><Reference><Citation>Tainer J.A., Getzoff E.D., Richardson J.S., Richardson D.C. Structure and mechanism of copper, zinc superoxide dismutase. Nature. 1983;306:284&#x2013;287.</Citation><ArticleIdList><ArticleId IdType="pubmed">6316150</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas K.A., Rubin B.H., Bier C.J., Richardson J.S., Richardson D.C. The crystal structure of bovine Cu2+,Zn2+ superoxide dismutase at 5.5-A resolution. J.&#xa0;Biol. Chem. 1974;249:5677&#x2013;5683.</Citation><ArticleIdList><ArticleId IdType="pubmed">4472353</ArticleId></ArticleIdList></Reference><Reference><Citation>Santamaria N., Alhothali M., Alfonso M.H., Breydo L., Uversky V.N. Intrinsic disorder in proteins involved in amyotrophic lateral sclerosis. Cell Mol. Life Sci. 2017;74:1297&#x2013;1318.</Citation><ArticleIdList><ArticleId IdType="pubmed">27838743</ArticleId></ArticleIdList></Reference><Reference><Citation>Abel O., Powell J.F., Andersen P.M., Al-Chalabi A. ALSoD: a user-friendly online bioinformatics tool for amyotrophic lateral sclerosis genetics. Hum. Mutat. 2012;33:1345&#x2013;1351.</Citation><ArticleIdList><ArticleId IdType="pubmed">22753137</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari A., Xu Z., Hayward L.J. Aberrantly increased hydrophobicity shared by mutants of Cu,Zn-superoxide dismutase in familial amyotrophic lateral sclerosis. J.&#xa0;Biol. Chem. 2005;280:29771&#x2013;29779.</Citation><ArticleIdList><ArticleId IdType="pubmed">15958382</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare S.D., Caplow M., Dokholyan N.V. FALS mutations in Cu, Zn superoxide dismutase destabilize the dimer and increase dimer dissociation propensity: a large-scale thermodynamic analysis. Amyloid. 2006;13:226&#x2013;235.</Citation><ArticleIdList><ArticleId IdType="pubmed">17107883</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmitt N.D., Agar J.N. Parsing disease-relevant protein modifications from epiphenomena: perspective on the structural basis of SOD1-mediated ALS. J.&#xa0;Mass Spectrom. 2017;52:480&#x2013;491.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6002871</ArticleId><ArticleId IdType="pubmed">28558143</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosco D.A., Morfini G., Karabacak N.M., Song Y., Gros-Louis F., Pasinelli P., et al. Wild-type and mutant SOD1 share an aberrant conformation and a common pathogenic pathway in ALS. Nat. Neurosci. 2010;13:1396&#x2013;1403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2967729</ArticleId><ArticleId IdType="pubmed">20953194</ArticleId></ArticleIdList></Reference><Reference><Citation>Kabashi E., Valdmanis P.N., Dion P., Rouleau G.A. Oxidized/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis? Ann. Neurol. 2007;62:553&#x2013;559.</Citation><ArticleIdList><ArticleId IdType="pubmed">18074357</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W.C., Liang J.Z., Li C., He Z.X., Yuan H.Y., Huang B.Y., et al. Pathological hydrogen peroxide triggers the fibrillization of wild-type SOD1 via sulfenic acid modification of Cys-111. Cell Death Dis. 2018;9:67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5833406</ArticleId><ArticleId IdType="pubmed">29358575</ArticleId></ArticleIdList></Reference><Reference><Citation>Molliex A., Temirov J., Lee J., Coughlin M., Kanagaraj A.P., Kim H.J., et al. Phase separation by low complexity domains promotes stress granule assembly and drives pathological fibrillization. Cell. 2015;163:123&#x2013;133.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5149108</ArticleId><ArticleId IdType="pubmed">26406374</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A., Lee H.O., Jawerth L., Maharana S., Jahnel M., Hein M.Y., et al. A&#xa0;liquid-to-solid phase transition of the ALS protein FUS accelerated by disease mutation. Cell. 2015;162:1066&#x2013;1077.</Citation><ArticleIdList><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegmann S., Eftekharzadeh B., Tepper K., Zoltowska K.M., Bennett R.E., Dujardin S., et al. Tau protein liquid-liquid phase separation can initiate tau aggregation. EMBO J. 2018;37</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5881631</ArticleId><ArticleId IdType="pubmed">29472250</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin Y., Brangwynne C.P. Liquid phase condensation in cell physiology and disease. Science. 2017;357</Citation><ArticleIdList><ArticleId IdType="pubmed">28935776</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z., Zhang S., Gu J., Tong Y., Li Y., Gui X., et al. Hsp27 chaperones FUS phase separation under the modulation of stress-induced phosphorylation. Nat. Struct. Mol. Biol. 2020;27:363&#x2013;372.</Citation><ArticleIdList><ArticleId IdType="pubmed">32231288</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyko S., Surewicz K., Surewicz W.K. Regulatory mechanisms of tau protein fibrillation under the conditions of liquid-liquid phase separation. Proc. Natl. Acad. Sci. U. S. A. 2020;117:31882&#x2013;31890.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7749306</ArticleId><ArticleId IdType="pubmed">33262278</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezzi S.A., Urushitani M., Julien J.P. Wild-type superoxide dismutase acquires binding and toxic properties of ALS-linked mutant forms through oxidation. J.&#xa0;Neurochem. 2007;102:170&#x2013;178.</Citation><ArticleIdList><ArticleId IdType="pubmed">17394546</ArticleId></ArticleIdList></Reference><Reference><Citation>Guareschi S., Cova E., Cereda C., Ceroni M., Donetti E., Bosco D.A., et al. An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1. Proc. Natl. Acad. Sci. U. S. A. 2012;109:5074&#x2013;5079.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3324021</ArticleId><ArticleId IdType="pubmed">22416121</ArticleId></ArticleIdList></Reference><Reference><Citation>Anzai I., Tokuda E., Mukaiyama A., Akiyama S., Endo F., Yamanaka K., et al. A&#xa0;misfolded dimer of Cu/Zn-superoxide dismutase leading to pathological oligomerization in amyotrophic lateral sclerosis. Protein Sci. 2017;26:484&#x2013;496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5326558</ArticleId><ArticleId IdType="pubmed">27977888</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu Y.P., Sun Y.C., Qiu D.C., Lin Y.H., Chen Y.Q., Kuo J.C., et al. Liquid-liquid phase separation and extracellular multivalent interactions in the tale of galectin-3. Nat. Commun. 2020;11:1229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7060198</ArticleId><ArticleId IdType="pubmed">32144274</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X., Wang L., Ishikawa R., Li Y., Fiedler M., Liu F., et al. Arabidopsis FLL2 promotes liquid-liquid phase separation of polyadenylation complexes. Nature. 2019;569:265&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6625965</ArticleId><ArticleId IdType="pubmed">31043738</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y., Protter D.S., Rosen M.K., Parker R. Formation and maturation of phase-separated liquid droplets by RNA-binding proteins. Mol. Cell. 2015;60:208&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4609299</ArticleId><ArticleId IdType="pubmed">26412307</ArticleId></ArticleIdList></Reference><Reference><Citation>Uversky V.N. The roles of intrinsic disorder-based liquid-liquid phase transitions in the &#x201c;Dr. Jekyll-Mr. Hyde&#x201d; behavior of proteins involved in amyotrophic lateral sclerosis and frontotemporal lobar degeneration. Autophagy. 2017;13:2115&#x2013;2162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5788550</ArticleId><ArticleId IdType="pubmed">28980860</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundaramoorthy V., Walker A.K., Yerbury J., Soo K.Y., Farg M.A., Hoang V., et al. Extracellular wildtype and mutant SOD1 induces ER-Golgi pathology characteristic of amyotrophic lateral sclerosis in neuronal cells. Cell Mol. Life Sci. 2013;70:4181&#x2013;4195.</Citation><ArticleIdList><ArticleId IdType="pubmed">23765103</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu C., Beck M.V., Griffith J.D., Deshmukh M., Dokholyan N.V. Large SOD1 aggregates, unlike trimeric SOD1, do not impact cell viability in a model of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2018;115:4661&#x2013;4665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5939103</ArticleId><ArticleId IdType="pubmed">29666246</ArticleId></ArticleIdList></Reference><Reference><Citation>Coelho F.R., Iqbal A., Linares E., Silva D.F., Lima F.S., Cuccovia I.M., et al. Oxidation of the tryptophan 32 residue of human superoxide dismutase 1 caused by its bicarbonate-dependent peroxidase activity triggers the non-amyloid aggregation of the enzyme. J.&#xa0;Biol. Chem. 2014;289:30690&#x2013;30701.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4215247</ArticleId><ArticleId IdType="pubmed">25237191</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad L.I., Guest W.C., Yanai A., Pokrishevsky E., O'Neill M.A., Gibbs E., et al. Intermolecular transmission of superoxide dismutase 1 misfolding in living cells. Proc. Natl. Acad. Sci. U. S. A. 2011;108:16398&#x2013;16403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3182705</ArticleId><ArticleId IdType="pubmed">21930926</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujiwara N., Nakano M., Kato S., Yoshihara D., Ookawara T., Eguchi H., et al. Oxidative modification to cysteine sulfonic acid of Cys111 in human copper-zinc superoxide dismutase. J.&#xa0;Biol. Chem. 2007;282:35933&#x2013;35944.</Citation><ArticleIdList><ArticleId IdType="pubmed">17913710</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto G., Stojanovic A., Holmberg C.I., Kim S., Morimoto R.I. Structural properties and neuronal toxicity of amyotrophic lateral sclerosis-associated Cu/Zn superoxide dismutase 1 aggregates. J.&#xa0;Cell Biol. 2005;171:75&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2171239</ArticleId><ArticleId IdType="pubmed">16216923</ArticleId></ArticleIdList></Reference><Reference><Citation>Weisberg S.J., Lyakhovetsky R., Werdiger A.C., Gitler A.D., Soen Y., Kaganovich D. Compartmentalization of superoxide dismutase 1 (SOD1G93A) aggregates determines their toxicity. Proc. Natl. Acad. Sci. U. S. A. 2012;109:15811&#x2013;15816.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3465386</ArticleId><ArticleId IdType="pubmed">22967507</ArticleId></ArticleIdList></Reference><Reference><Citation>McAlary L., Aquilina J.A., Yerbury J.J. Susceptibility of mutant SOD1 to form a destabilized monomer predicts cellular aggregation and toxicity but not in&#xa0;vitro aggregation propensity. Front Neurosci. 2016;10:499.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5095133</ArticleId><ArticleId IdType="pubmed">27867347</ArticleId></ArticleIdList></Reference><Reference><Citation>Dao T.P., Martyniak B., Canning A.J., Lei Y., Colicino E.G., Cosgrove M.S., et al. ALS-linked mutations affect UBQLN2 oligomerization and phase separation in a position- and amino acid-dependent manner. Structure. 2019;27:937&#x2013;951.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6551275</ArticleId><ArticleId IdType="pubmed">30982635</ArticleId></ArticleIdList></Reference><Reference><Citation>Petronilho E.C., Pedrote M.M., Marques M.A., Passos Y.M., Mota M.F., Jakobus B., et al. Phase separation of p53 precedes aggregation and is affected by oncogenic mutations and ligands. Chem. Sci. 2021;12:7334&#x2013;7349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8171334</ArticleId><ArticleId IdType="pubmed">34163823</ArticleId></ArticleIdList></Reference><Reference><Citation>Babinchak W.M., Haider R., Dumm B.K., Sarkar P., Surewicz K., Choi J.K., et al. The role of liquid-liquid phase separation in aggregation of the TDP-43 low-complexity domain. J.&#xa0;Biol. Chem. 2019;294:6306&#x2013;6317.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6484124</ArticleId><ArticleId IdType="pubmed">30814253</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T., Faraggi E., Li Z., Zhou Y. Intrinsically semi-disordered state and its role in induced folding and protein aggregation. Cell Biochem. Biophys. 2013;67:1193&#x2013;1205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3838602</ArticleId><ArticleId IdType="pubmed">23723000</ArticleId></ArticleIdList></Reference><Reference><Citation>Parge H.E., Hallewell R.A., Tainer J.A. Atomic structures of wild-type and thermostable mutant recombinant human Cu,Zn superoxide dismutase. Proc. Natl. Acad. Sci. U. S. A. 1992;89:6109&#x2013;6113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC49447</ArticleId><ArticleId IdType="pubmed">1463506</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrawell N.E., Lambert-Smith I.A., Warraich S.T., Blair I.P., Saunders D.N., Hatters D.M., et al. Distinct partitioning of ALS associated TDP-43, FUS and SOD1 mutants into cellular inclusions. Sci. Rep. 2015;5:13416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4544019</ArticleId><ArticleId IdType="pubmed">26293199</ArticleId></ArticleIdList></Reference><Reference><Citation>Mateju D., Franzmann T.M., Patel A., Kopach A., Boczek E.E., Maharana S., et al. An aberrant phase transition of stress granules triggered by misfolded protein and prevented by chaperone function. EMBO J. 2017;36:1669&#x2013;1687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5470046</ArticleId><ArticleId IdType="pubmed">28377462</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitamura F., Fujimaki N., Okita W., Hiramatsu H., Takeuchi H. Structural instability and Cu-dependent pro-oxidant activity acquired by the apo form of mutant SOD1 associated with amyotrophic lateral sclerosis. Biochemistry. 2011;50:4242&#x2013;4250.</Citation><ArticleIdList><ArticleId IdType="pubmed">21506602</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimaki N., Kitamura F., Takeuchi H. Pro-oxidant copper-binding mode of the Apo form of ALS-linked SOD1 mutant H43R denatured at physiological temperature. Biochemistry. 2013;52:5184&#x2013;5194.</Citation><ArticleIdList><ArticleId IdType="pubmed">23837654</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulligan V.K., Kerman A., Laister R.C., Sharda P.R., Arslan P.E., Chakrabartty A. Early steps in oxidation-induced SOD1 misfolding: implications for non-amyloid protein aggregation in familial ALS. J.&#xa0;Mol. Biol. 2012;421:631&#x2013;652.</Citation><ArticleIdList><ArticleId IdType="pubmed">22542526</ArticleId></ArticleIdList></Reference><Reference><Citation>Anzai I., Tokuda E., Handa S., Misawa H., Akiyama S., Furukawa Y. Oxidative misfolding of Cu/Zn-superoxide dismutase triggered by non-canonical intramolecular disulfide formation. Free Radic. Biol. Med. 2020;147:187&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pubmed">31863908</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiwari M.K., Hagglund P.M., Moller I.M., Davies M.J., Bjerrum M.J. Copper ion/H2O2 oxidation of Cu/Zn-superoxide dismutase: implications for enzymatic activity and antioxidant action. Redox Biol. 2019;26:101262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6614508</ArticleId><ArticleId IdType="pubmed">31284117</ArticleId></ArticleIdList></Reference><Reference><Citation>Wright G.S., Antonyuk S.V., Kershaw N.M., Strange R.W., Samar Hasnain S. Ligand binding and aggregation of pathogenic SOD1. Nat. Commun. 2013;4:1758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3644087</ArticleId><ArticleId IdType="pubmed">23612299</ArticleId></ArticleIdList></Reference><Reference><Citation>Pokrishevsky E., Hong R.H., Mackenzie I.R., Cashman N.R. Spinal cord homogenates from SOD1 familial amyotrophic lateral sclerosis induce SOD1 aggregation in living cells. PLoS One. 2017;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5587256</ArticleId><ArticleId IdType="pubmed">28877271</ArticleId></ArticleIdList></Reference><Reference><Citation>Capper M.J., Wright G.S.A., Barbieri L., Luchinat E., Mercatelli E., McAlary L., et al. The cysteine-reactive small molecule ebselen facilitates effective SOD1 maturation. Nat. Commun. 2018;9:1693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5923229</ArticleId><ArticleId IdType="pubmed">29703933</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts K., Zeineddine R., Corcoran L., Li W., Campbell I.L., Yerbury J.J. Extracellular aggregated Cu/Zn superoxide dismutase activates microglia to give a cytotoxic phenotype. Glia. 2013;61:409&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pubmed">23281114</ArticleId></ArticleIdList></Reference><Reference><Citation>Sangwan S., Zhao A., Adams K.L., Jayson C.K., Sawaya M.R., Guenther E.L., et al. Atomic structure of a toxic, oligomeric segment of SOD1 linked to amyotrophic lateral sclerosis (61) Proc. Natl. Acad. Sci. U. S. A. 2017;114:8770&#x2013;8775.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5565441</ArticleId><ArticleId IdType="pubmed">28760994</ArticleId></ArticleIdList></Reference><Reference><Citation>Hough M.A., Grossmann J.G., Antonyuk S.V., Strange R.W., Doucette P.A., Rodriguez J.A., et al. Dimer destabilization in superoxide dismutase may result in disease-causing properties: structures of motor neuron disease mutants. Proc. Natl. Acad. Sci. U. S. A. 2004;101:5976&#x2013;5981.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC395908</ArticleId><ArticleId IdType="pubmed">15056757</ArticleId></ArticleIdList></Reference><Reference><Citation>Galaleldeen A., Strange R.W., Whitson L.J., Antonyuk S.V., Narayana N., Taylor A.B., et al. Structural and biophysical properties of metal-free pathogenic SOD1 mutants A4V and G93A. Arch. Biochem. Biophys. 2009;492:40&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2787720</ArticleId><ArticleId IdType="pubmed">19800308</ArticleId></ArticleIdList></Reference><Reference><Citation>Tachu B.J., Wusten K.A., Garza M.C., Wille H., Tamguney G. An easy method for bacterial expression and purification of wild-type and mutant superoxide dismutase 1 (SOD1) Protein Expr. Purif. 2017;134:63&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">28385582</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding X., Sun F., Chen J., Chen L., Tobin-Miyaji Y., Xue S., et al. Amyloid-forming segment induces aggregation of FUS-LC domain from phase separation modulated by site-specific phosphorylation. J.&#xa0;Mol. Biol. 2020;432:467&#x2013;483.</Citation><ArticleIdList><ArticleId IdType="pubmed">31805282</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>